Clinical trial
Marinobufagenin as a Target for DIGIBIND in Preeclampsia
NCT01328600 is registered in ClinicalTrials.gov with National Institute on Aging (NIA) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Marinobufagenin as a Target for DIGIBIND in Preeclampsia
- Lead sponsor
- National Institute on Aging (NIA)
- Phase
- Observational
- Overall status
- Completed
- Start date
- August 16, 2006
- Completion date
- July 29, 2014
- Enrollment
- 144 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
preeclampsia